Trial intelligence / Profile preview

Impact of gastric motility on gastrointestinal behavior and systemic exposure of fosamprenavir in healthy volunteers

2016-005043-16Phase 4Completed

Sponsor
KU Leuven
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of fosamprenavir, sponsored by KU Leuven. Started Jan 2020; status: completed.

02

Drugs

fosamprenavir

Beyond the preview

Go deeper on 2016-005043-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-005043-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call